Coreleased Orexin and Glutamate Evoke Nonredundant Spike Outputs and Computations in Histamine Neurons

Cell Reports

Volumn 7, Issue 3, 2014, Pages 697-704

  Schöne, Cornelia ^a   Apergis Schoute, John ^b   Sakurai, Takeshi ^c,d   Adamantidis, Antoine ^e,f   Burdakov, Denis ^a,g  

^a NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c KANAZAWA UNIVERSITY   (Japan)

^d UNIVERSITY OF TSUKUBA   (Japan)

^e UNIVERSITY OF BERN   (Switzerland)

^f MCGILL UNIVERSITY   (Canada)

^g KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMIC ACID; HISTAMINE; OREXIN; OREXIN 2 RECEPTOR; G PROTEIN COUPLED RECEPTOR; NEUROPEPTIDE; SIGNAL PEPTIDE;

ARTICLE; BRAIN NERVE CELL; CONTROLLED STUDY; HISTAMINE NEURON; MOUSE; NERVE CELL STIMULATION; NEUROMODULATION; NEUROTRANSMISSION; NONHUMAN; OPTOGENETICS; POSTSYNAPTIC POTENTIAL; PRIORITY JOURNAL; PROTEIN SECRETION; SIGNAL TRANSDUCTION; SPIKE WAVE; ANIMAL EXPERIMENT; CONCEPTUAL FRAMEWORK; DOWNSTREAM PROCESSING; EVOKED RESPONSE; NERVE CELL; PROTEIN BLOOD LEVEL; SIMULATION; ANIMAL; BIOLOGICAL MODEL; C57BL MOUSE; FEMALE; MALE; METABOLISM; SYNAPTIC TRANSMISSION;

ANIMALS; FEMALE; GLUTAMIC ACID; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MICE, INBRED C57BL; MODELS, BIOLOGICAL; NEURONS; NEUROPEPTIDES; OREXINS; RECEPTORS, G-PROTEIN-COUPLED; SYNAPTIC TRANSMISSION;

EID: 84899939007     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2014.03.055     Document Type: Article

References (56)

1. Adamantidis A.R., Zhang F., Aravanis A.M., Deisseroth K., de Lecea L. Neural substrates of awakening probed with optogenetic control of hypocretin neurons. Nature 2007, 450:420-424.
2. Aström K., Hagglund T. PID Controllers: Theory, Design, and Tuning 1995, Instrument Society of America, Research Triangle Park.
3. Bear M.F., Connors B.W., Paradiso M.A. Neuroscience: Exploring the Brain 2001, Lippincott Williams & Wilkins, Philadelphia.
4. Burbach J.P. What are neuropeptides?. Methods Mol. Biol. 2011, 789:1-36.
5. Burnstock G. Cotransmission. Curr. Opin. Pharmacol. 2004, 4:47-52.
6. Carpenter R. Neurophysiology 2003, Arnold, London. Fourth Edition.
7. Chemelli R.M., Willie J.T., Sinton C.M., Elmquist J.K., Scammell T., Lee C., Richardson J.A., Williams S.C., Xiong Y., Kisanuki Y., et al. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 1999, 98:437-451.
8. Crocker A., España R.A., Papadopoulou M., Saper C.B., Faraco J., Sakurai T., Honda M., Mignot E., Scammell T.E. Concomitant loss of dynorphin, NARP, and orexin in narcolepsy. Neurology 2005, 65:1184-1188.
9. Csete M.E., Doyle J.C. Reverse engineering of biological complexity. Science 2002, 295:1664-1669.
10. de Lecea L., Kilduff T.S., Peyron C., Gao X., Foye P.E., Danielson P.E., Fukuhara C., Battenberg E.L., Gautvik V.T., Bartlett F.S., et al. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc. Natl. Acad. Sci. USA 1998, 95:322-327.
11. de Lecea L., Jones B.E., Boutrel B., Borgland S.L., Nishino S., Bubser M., DiLeone R. Addiction and arousal: alternative roles of hypothalamic peptides. J. Neurosci. 2006, 26:10372-10375.
12. DiStefano J., Stubberud A., Williams I. Feedback and Control Systems, Second Edition 2012, McGraw-Hill Education, New York.
13. Dutton A., Dyball R.E. Phasic firing enhances vasopressin release from the rat neurohypophysis. J. Physiol. 1979, 290:433-440.
14. Eriksson K.S., Sergeeva O., Brown R.E., Haas H.L. Orexin/hypocretin excites the histaminergic neurons of the tuberomammillary nucleus. J. Neurosci. 2001, 21:9273-9279.
15. Furutani N., Hondo M., Kageyama H., Tsujino N., Mieda M., Yanagisawa M., Shioda S., Sakurai T. Neurotensin co-expressed in orexin-producing neurons in the lateral hypothalamus plays an important role in regulation of sleep/wakefulness states. PLoS ONE 2013, 8:e62391.
16. Haas H.L., Reiner P.B. Membrane properties of histaminergic tuberomammillary neurones of the rat hypothalamus in vitro. J. Physiol. 1988, 399:633-646.
17. Haas H.L., Sergeeva O.A., Selbach O. Histamine in the nervous system. Physiol. Rev. 2008, 88:1183-1241.
18. Haass M., Cheng B., Richardt G., Lang R.E., Schömig A. Characterization and presynaptic modulation of stimulation-evoked exocytotic co-release of noradrenaline and neuropeptide Y in guinea pig heart. Naunyn Schmiedebergs Arch. Pharmacol. 1989, 339:71-78.
19. Hara J., Beuckmann C.T., Nambu T., Willie J.T., Chemelli R.M., Sinton C.M., Sugiyama F., Yagami K., Goto K., Yanagisawa M., Sakurai T. Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity. Neuron 2001, 30:345-354.
20. Hirose M., Egashira S., Goto Y., Hashihayata T., Ohtake N., Iwaasa H., Hata M., Fukami T., Kanatani A., Yamada K. N-acyl 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline: the first orexin-2 receptor selective non-peptidic antagonist. Bioorg. Med. Chem. Lett. 2003, 13:4497-4499.
21. Huang S.C., Dai Y.W., Lee Y.H., Chiou L.C., Hwang L.L. Orexins depolarize rostral ventrolateral medulla neurons and increase arterial pressure and heart rate in rats mainly via orexin 2 receptors. J. Pharmacol. Exp. Ther. 2010, 334:522-529.
22. Lambe E.K., Aghajanian G.K. Hypocretin (orexin) induces calcium transients in single spines postsynaptic to identified thalamocortical boutons in prefrontal slice. Neuron 2003, 40:139-150.
23. Lee M.G., Hassani O.K., Jones B.E. Discharge of identified orexin/hypocretin neurons across the sleep-waking cycle. J. Neurosci. 2005, 25:6716-6720.
24. Li Y., Gao X.B., Sakurai T., van den Pol A.N. Hypocretin/Orexin excites hypocretin neurons via a local glutamate neuron-A potential mechanism for orchestrating the hypothalamic arousal system. Neuron 2002, 36:1169-1181.
25. Lin L., Faraco J., Li R., Kadotani H., Rogers W., Lin X., Qiu X., de Jong P.J., Nishino S., Mignot E. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 1999, 98:365-376.
26. Lundberg J.M., Rudehill A., Sollevi A., Theodorsson-Norheim E., Hamberger B. Frequency- and reserpine-dependent chemical coding of sympathetic transmission: differential release of noradrenaline and neuropeptide Y from pig spleen. Neurosci. Lett. 1986, 63:96-100.
27. Ma X., Zubcevic L., Brüning J.C., Ashcroft F.M., Burdakov D. Electrical inhibition of identified anorexigenic POMC neurons by orexin/hypocretin. J. Neurosci. 2007, 27:1529-1533.
28. Matsuki T., Nomiyama M., Takahira H., Hirashima N., Kunita S., Takahashi S., Yagami K., Kilduff T.S., Bettler B., Yanagisawa M., Sakurai T. Selective loss of GABA(B) receptors in orexin-producing neurons results in disrupted sleep/wakefulness architecture. Proc. Natl. Acad. Sci. USA 2009, 106:4459-4464.
29. Mignot E., Taheri S., Nishino S. Sleeping with the hypothalamus: emerging therapeutic targets for sleep disorders. Nat. Neurosci. 2002, 5(Suppl):1071-1075.
30. Mileykovskiy B.Y., Kiyashchenko L.I., Siegel J.M. Behavioral correlates of activity in identified hypocretin/orexin neurons. Neuron 2005, 46:787-798.
31. Mochizuki T., Arrigoni E., Marcus J.N., Clark E.L., Yamamoto M., Honer M., Borroni E., Lowell B.B., Elmquist J.K., Scammell T.E. Orexin receptor 2 expression in the posterior hypothalamus rescues sleepiness in narcoleptic mice. Proc. Natl. Acad. Sci. USA 2011, 108:4471-4476.
32. Petreanu L., Huber D., Sobczyk A., Svoboda K. Channelrhodopsin-2-assisted circuit mapping of long-range callosal projections. Nat. Neurosci. 2007, 10:663-668.
33. Peyron C., Tighe D.K., van den Pol A.N., de Lecea L., Heller H.C., Sutcliffe J.G., Kilduff T.S. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J. Neurosci. 1998, 18:9996-10015.
34. Peyron C., Faraco J., Rogers W., Ripley B., Overeem S., Charnay Y., Nevsimalova S., Aldrich M., Reynolds D., Albin R., et al. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat. Med. 2000, 6:991-997.
35. Ren J., Qin C., Hu F., Tan J., Qiu L., Zhao S., Feng G., Luo M. Habenula "cholinergic" neurons co-release glutamate and acetylcholine and activate postsynaptic neurons via distinct transmission modes. Neuron 2011, 69:445-452.
36. Ripley B., Fujiki N., Okura M., Mignot E., Nishino S. Hypocretin levels in sporadic and familial cases of canine narcolepsy. Neurobiol. Dis. 2001, 8:525-534.
37. Sakurai T. The neural circuit of orexin (hypocretin): maintaining sleep and wakefulness. Nat. Rev. Neurosci. 2007, 8:171-181.
38. Sakurai T., Amemiya A., Ishii M., Matsuzaki I., Chemelli R.M., Tanaka H., Williams S.C., Richardson J.A., Kozlowski G.P., Wilson S., et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 1998, 92:573-585.
39. Salio C., Lossi L., Ferrini F., Merighi A. Neuropeptides as synaptic transmitters. Cell Tissue Res. 2006, 326:583-598.
40. Schöne C., Burdakov D. Glutamate and GABA as rapid effectors of hypothalamic "peptidergic" neurons. Front. Behav. Neurosci. 2012, 6:81.
41. Schöne C., Cao Z.F., Apergis-Schoute J., Adamantidis A., Sakurai T., Burdakov D. Optogenetic probing of fast glutamatergic transmission from hypocretin/orexin to histamine neurons in situ. J. Neurosci. 2012, 32:12437-12443.
42. Smart D., Sabido-David C., Brough S.J., Jewitt F., Johns A., Porter R.A., Jerman J.C. SB-334867-A: the first selective orexin-1 receptor antagonist. Br. J. Pharmacol. 2001, 132:1179-1182.
43. Thannickal T.C., Moore R.Y., Nienhuis R., Ramanathan L., Gulyani S., Aldrich M., Cornford M., Siegel J.M. Reduced number of hypocretin neurons in human narcolepsy. Neuron 2000, 27:469-474.
44. van den Pol A.N. Weighing the role of hypothalamic feeding neurotransmitters. Neuron 2003, 40:1059-1061.
45. van den Pol A.N. Neuropeptide transmission in brain circuits. Neuron 2012, 76:98-115.
46. van den Pol A.N., Gao X.B., Obrietan K., Kilduff T.S., Belousov A.B. Presynaptic and postsynaptic actions and modulation of neuroendocrine neurons by a new hypothalamic peptide, hypocretin/orexin. J. Neurosci. 1998, 18:7962-7971.
47. Verhage M., McMahon H.T., Ghijsen W.E., Boomsma F., Scholten G., Wiegant V.M., Nicholls D.G. Differential release of amino acids, neuropeptides, and catecholamines from isolated nerve terminals. Neuron 1991, 6:517-524.
48. Williams R.H., Jensen L.T., Verkhratsky A., Fugger L., Burdakov D. Control of hypothalamic orexin neurons by acid and CO2. Proc. Natl. Acad. Sci. USA 2007, 104:10685-10690.
49. Williams R.H., Alexopoulos H., Jensen L.T., Fugger L., Burdakov D. Adaptive sugar sensors in hypothalamic feeding circuits. Proc. Natl. Acad. Sci. USA 2008, 105:11975-11980.
50. Willie J.T., Chemelli R.M., Sinton C.M., Tokita S., Williams S.C., Kisanuki Y.Y., Marcus J.N., Lee C., Elmquist J.K., Kohlmeier K.A., et al. Distinct narcolepsy syndromes in Orexin receptor-2 and Orexin null mice: molecular genetic dissection of Non-REM and REM sleep regulatory processes. Neuron 2003, 38:715-730.
51. Winsky-Sommerer R., Yamanaka A., Diano S., Borok E., Roberts A.J., Sakurai T., Kilduff T.S., Horvath T.L., de Lecea L. Interaction between the corticotropin-releasing factor system and hypocretins (orexins): a novel circuit mediating stress response. J. Neurosci. 2004, 24:11439-11448.
52. Woldan-Tambor A., Biegańska K., Wiktorowska-Owczarek A., Zawilska J.B. Activation of orexin/hypocretin type 1 receptors stimulates cAMP synthesis in primary cultures of rat astrocytes. Pharmacol. Rep. 2011, 63:717-723.
53. Xiao F., Jiang M., Du D., Xia C., Wang J., Cao Y., Shen L., Zhu D. Orexin A regulates cardiovascular responses in stress-induced hypertensive rats. Neuropharmacology 2013, 67:16-24.
54. Yamanaka A., Tsujino N., Funahashi H., Honda K., Guan J.L., Wang Q.P., Tominaga M., Goto K., Shioda S., Sakurai T. Orexins activate histaminergic neurons via the orexin 2 receptor. Biochem. Biophys. Res. Commun. 2002, 290:1237-1245.
55. Yi T.M., Huang Y., Simon M.I., Doyle J. Robust perfect adaptation in bacterial chemotaxis through integral feedback control. Proc. Natl. Acad. Sci. USA 2000, 97:4649-4653.
56. Yizhar O., Fenno L.E., Davidson T.J., Mogri M., Deisseroth K. Optogenetics in neural systems. Neuron 2011, 71:9-34.